Miguel
Alcoceba Sánchez
Investigador desde 2011
Elías
Campo Güerri
Publicaciones en las que colabora con Elías Campo Güerri (10)
2023
-
IGLV3-21R110 mutation has prognostic value in patients with treatment-naive chronic lymphocytic leukemia
Blood Advances
-
Unraveling the genetics of transformed splenic marginal zone lymphoma
Blood Advances, Vol. 7, Núm. 14, pp. 3695-3709
2022
-
Clinico-biological features and outcome of patients with splenic marginal zone lymphoma with histological transformation
British Journal of Haematology, Vol. 196, Núm. 1, pp. 146-155
-
Detection of early seeding of Richter transformation in chronic lymphocytic leukemia
Nature Medicine, Vol. 28, Núm. 8, pp. 1662-1671
-
Revised International Prognostic Index and genetic alterations are associated with early failure to R-CHOP in patients with diffuse large B-cell lymphoma
British Journal of Haematology, Vol. 196, Núm. 3, pp. 589-598
2019
-
Mutations in the RAS-BRAF-MAPK-ERK pathway define a specific subgroup of patients with adverse clinical features and provide new therapeutic options in chronic lymphocytic leukemia
Haematologica, Vol. 104, Núm. 3, pp. 576-586
2018
-
Clinical impact of the subclonal architecture and mutational complexity in chronic lymphocytic leukemia
Leukemia, Vol. 32, Núm. 3, pp. 645-653
-
Integrating genomic alterations in diffuse large B-cell lymphoma identifies new relevant pathways and potential therapeutic targets
Leukemia, Vol. 32, Núm. 3, pp. 675-684
-
The mutational landscape of small lymphocytic lymphoma compared to non-early stage chronic lymphocytic leukemia
Leukemia and Lymphoma, Vol. 59, Núm. 10, pp. 2318-2326
2016
-
Clinical impact of clonal and subclonal TP53, SF3B1, BIRC3, NOTCH1, and ATM mutations in chronic lymphocytic leukemia
Blood, Vol. 127, Núm. 17, pp. 2122-2130